Skip to main content
Top
Published in: European Journal of Clinical Microbiology & Infectious Diseases 12/2014

01-12-2014 | Article

Evaluation of the Bruker Biotyper and VITEK MS MALDI-TOF MS systems for the identification of unusual and/or difficult-to-identify microorganisms isolated from clinical specimens

Authors: E. McElvania TeKippe, C.-A. D. Burnham

Published in: European Journal of Clinical Microbiology & Infectious Diseases | Issue 12/2014

Login to get access

Abstract

The purpose of this investigation was to evaluate the analytical performance characteristics of matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS) for the identification of unusual organisms. We evaluated the accuracy of two MALDI-TOF MS systems, bioMérieux VITEK MS (database v2.0) and Bruker Biotyper (software version 3.0), for the identification of the most difficult and/or unusual microorganisms isolated from clinical specimens. Our study included 174 bacterial isolates recovered from clinical cultures at Barnes-Jewish Hospital, St. Louis, MO, from 2009 to 2013, representing 50 genera and 52 species. MS identifications were compared to the identification reported by the reference laboratory. Discrepancies were resolved using molecular methods, including 16S rRNA gene sequencing and additional molecular methods. When performed, molecular methods were considered the gold standard. Of the 168 isolates resolved to the genus level, VITEK MS identified 145 (86.3 %), and of the 114 isolates resolved to the species level, 97 (85.1 %) were correctly identified. Bruker Biotyper identified 155 (92.3 %) of 168 isolates to the genus level and 97 (85.1 %) of 114 isolates to the species level. VITEK MS and Bruker Biotyper provided no identification for 17 (10.1 %) and 12 (7.1 %) organisms, respectively, and misidentified six (3.6 %) and one (0.6 %) isolate, respectively. Six isolates (3.6 %) were not resolvable to the genus level and were excluded from data analysis due to the lack of a gold standard for comparison. There was no significant difference in the number of organisms identified to the genus level, species level, unidentified, or misidentified by the two MALDI-TOF MS systems (p = 0.11, 1.0, 0.44, and 0.12, respectively).
Literature
1.
go back to reference Ford BA, Burnham CA (2013) Optimization of routine identification of clinically relevant Gram-negative bacteria by use of matrix-assisted laser desorption ionization-time of flight mass spectrometry and the Bruker Biotyper. J Clin Microbiol 51(5):1412–1420. doi:10.1128/JCM.01803-12 CrossRefPubMedPubMedCentral Ford BA, Burnham CA (2013) Optimization of routine identification of clinically relevant Gram-negative bacteria by use of matrix-assisted laser desorption ionization-time of flight mass spectrometry and the Bruker Biotyper. J Clin Microbiol 51(5):1412–1420. doi:10.​1128/​JCM.​01803-12 CrossRefPubMedPubMedCentral
2.
go back to reference McElvania Tekippe E, Shuey S, Winkler DW, Butler MA, Burnham CA (2013) Optimizing identification of clinically relevant Gram-positive organisms by use of the Bruker Biotyper matrix-assisted laser desorption ionization-time of flight mass spectrometry system. J Clin Microbiol 51(5):1421–1427. doi:10.1128/JCM.02680-12 CrossRefPubMedPubMedCentral McElvania Tekippe E, Shuey S, Winkler DW, Butler MA, Burnham CA (2013) Optimizing identification of clinically relevant Gram-positive organisms by use of the Bruker Biotyper matrix-assisted laser desorption ionization-time of flight mass spectrometry system. J Clin Microbiol 51(5):1421–1427. doi:10.​1128/​JCM.​02680-12 CrossRefPubMedPubMedCentral
3.
go back to reference Bizzini A, Durussel C, Bille J, Greub G, Prod’hom G (2010) Performance of matrix-assisted laser desorption ionization-time of flight mass spectrometry for identification of bacterial strains routinely isolated in a clinical microbiology laboratory. J Clin Microbiol 48(5):1549–1554. doi:10.1128/JCM.01794-09 CrossRefPubMedPubMedCentral Bizzini A, Durussel C, Bille J, Greub G, Prod’hom G (2010) Performance of matrix-assisted laser desorption ionization-time of flight mass spectrometry for identification of bacterial strains routinely isolated in a clinical microbiology laboratory. J Clin Microbiol 48(5):1549–1554. doi:10.​1128/​JCM.​01794-09 CrossRefPubMedPubMedCentral
4.
go back to reference Eigner U, Holfelder M, Oberdorfer K, Betz-Wild U, Bertsch D, Fahr AM (2009) Performance of a matrix-assisted laser desorption ionization-time-of-flight mass spectrometry system for the identification of bacterial isolates in the clinical routine laboratory. Clin Lab 55(7–8):289–296PubMed Eigner U, Holfelder M, Oberdorfer K, Betz-Wild U, Bertsch D, Fahr AM (2009) Performance of a matrix-assisted laser desorption ionization-time-of-flight mass spectrometry system for the identification of bacterial isolates in the clinical routine laboratory. Clin Lab 55(7–8):289–296PubMed
5.
go back to reference Neville SA, Lecordier A, Ziochos H, Chater MJ, Gosbell IB, Maley MW, van Hal SJ (2011) Utility of matrix-assisted laser desorption ionization-time of flight mass spectrometry following introduction for routine laboratory bacterial identification. J Clin Microbiol 49(8):2980–2984. doi:10.1128/JCM.00431-11 CrossRefPubMedPubMedCentral Neville SA, Lecordier A, Ziochos H, Chater MJ, Gosbell IB, Maley MW, van Hal SJ (2011) Utility of matrix-assisted laser desorption ionization-time of flight mass spectrometry following introduction for routine laboratory bacterial identification. J Clin Microbiol 49(8):2980–2984. doi:10.​1128/​JCM.​00431-11 CrossRefPubMedPubMedCentral
6.
go back to reference van Veen SQ, Claas EC, Kuijper EJ (2010) High-throughput identification of bacteria and yeast by matrix-assisted laser desorption ionization-time of flight mass spectrometry in conventional medical microbiology laboratories. J Clin Microbiol 48(3):900–907. doi:10.1128/JCM.02071-09 CrossRefPubMedPubMedCentral van Veen SQ, Claas EC, Kuijper EJ (2010) High-throughput identification of bacteria and yeast by matrix-assisted laser desorption ionization-time of flight mass spectrometry in conventional medical microbiology laboratories. J Clin Microbiol 48(3):900–907. doi:10.​1128/​JCM.​02071-09 CrossRefPubMedPubMedCentral
7.
go back to reference Risch M, Radjenovic D, Han JN, Wydler M, Nydegger U, Risch L (2010) Comparison of MALDI TOF with conventional identification of clinically relevant bacteria. Swiss Med Wkly 140:w13095. doi:10.4414/smw.2010.13095 PubMed Risch M, Radjenovic D, Han JN, Wydler M, Nydegger U, Risch L (2010) Comparison of MALDI TOF with conventional identification of clinically relevant bacteria. Swiss Med Wkly 140:w13095. doi:10.​4414/​smw.​2010.​13095 PubMed
8.
go back to reference Seng P, Drancourt M, Gouriet F, La Scola B, Fournier PE, Rolain JM, Raoult D (2009) Ongoing revolution in bacteriology: routine identification of bacteria by matrix-assisted laser desorption ionization time-of-flight mass spectrometry. Clin Infect Dis 49(4):543–551. doi:10.1086/600885 CrossRefPubMed Seng P, Drancourt M, Gouriet F, La Scola B, Fournier PE, Rolain JM, Raoult D (2009) Ongoing revolution in bacteriology: routine identification of bacteria by matrix-assisted laser desorption ionization time-of-flight mass spectrometry. Clin Infect Dis 49(4):543–551. doi:10.​1086/​600885 CrossRefPubMed
10.
go back to reference Cherkaoui A, Hibbs J, Emonet S, Tangomo M, Girard M, Francois P, Schrenzel J (2010) Comparison of two matrix-assisted laser desorption ionization-time of flight mass spectrometry methods with conventional phenotypic identification for routine identification of bacteria to the species level. J Clin Microbiol 48(4):1169–1175. doi:10.1128/JCM.01881-09 CrossRefPubMedPubMedCentral Cherkaoui A, Hibbs J, Emonet S, Tangomo M, Girard M, Francois P, Schrenzel J (2010) Comparison of two matrix-assisted laser desorption ionization-time of flight mass spectrometry methods with conventional phenotypic identification for routine identification of bacteria to the species level. J Clin Microbiol 48(4):1169–1175. doi:10.​1128/​JCM.​01881-09 CrossRefPubMedPubMedCentral
11.
go back to reference Jamal WY, Shahin M, Rotimi VO (2013) Comparison of two matrix-assisted laser desorption/ionization-time of flight (MALDI-TOF) mass spectrometry methods and API 20AN for identification of clinically relevant anaerobic bacteria. J Med Microbiol 62(Pt 4):540–544. doi:10.1099/jmm.0.053256-0 CrossRefPubMed Jamal WY, Shahin M, Rotimi VO (2013) Comparison of two matrix-assisted laser desorption/ionization-time of flight (MALDI-TOF) mass spectrometry methods and API 20AN for identification of clinically relevant anaerobic bacteria. J Med Microbiol 62(Pt 4):540–544. doi:10.​1099/​jmm.​0.​053256-0 CrossRefPubMed
12.
go back to reference Chen JH, Ho PL, Kwan GS, She KK, Siu GK, Cheng VC, Yuen KY, Yam WC (2013) Direct bacterial identification in positive blood cultures by use of two commercial matrix-assisted laser desorption ionization-time of flight mass spectrometry systems. J Clin Microbiol 51(6):1733–1739. doi:10.1128/JCM.03259-12 CrossRefPubMedPubMedCentral Chen JH, Ho PL, Kwan GS, She KK, Siu GK, Cheng VC, Yuen KY, Yam WC (2013) Direct bacterial identification in positive blood cultures by use of two commercial matrix-assisted laser desorption ionization-time of flight mass spectrometry systems. J Clin Microbiol 51(6):1733–1739. doi:10.​1128/​JCM.​03259-12 CrossRefPubMedPubMedCentral
13.
go back to reference Mancini N, De Carolis E, Infurnari L, Vella A, Clementi N, Vaccaro L, Ruggeri A, Posteraro B, Burioni R, Clementi M, Sanguinetti M (2013) Comparative evaluation of the Bruker Biotyper and Vitek MS matrix-assisted laser desorption ionization-time of flight (MALDI-TOF) mass spectrometry systems for identification of yeasts of medical importance. J Clin Microbiol 51(7):2453–2457. doi:10.1128/JCM.00841-13 CrossRefPubMedPubMedCentral Mancini N, De Carolis E, Infurnari L, Vella A, Clementi N, Vaccaro L, Ruggeri A, Posteraro B, Burioni R, Clementi M, Sanguinetti M (2013) Comparative evaluation of the Bruker Biotyper and Vitek MS matrix-assisted laser desorption ionization-time of flight (MALDI-TOF) mass spectrometry systems for identification of yeasts of medical importance. J Clin Microbiol 51(7):2453–2457. doi:10.​1128/​JCM.​00841-13 CrossRefPubMedPubMedCentral
14.
go back to reference Fang H, Ohlsson AK, Ullberg M, Ozenci V (2012) Evaluation of species-specific PCR, Bruker MS, VITEK MS and the VITEK 2 system for the identification of clinical Enterococcus isolates. Eur J Clin Microbiol Infect Dis 31(11):3073–3077. doi:10.1007/s10096-012-1667-x CrossRefPubMed Fang H, Ohlsson AK, Ullberg M, Ozenci V (2012) Evaluation of species-specific PCR, Bruker MS, VITEK MS and the VITEK 2 system for the identification of clinical Enterococcus isolates. Eur J Clin Microbiol Infect Dis 31(11):3073–3077. doi:10.​1007/​s10096-012-1667-x CrossRefPubMed
15.
go back to reference Marko DC, Saffert RT, Cunningham SA, Hyman J, Walsh J, Arbefeville S, Howard W, Pruessner J, Safwat N, Cockerill FR, Bossler AD, Patel R, Richter SS (2012) Evaluation of the Bruker Biotyper and Vitek MS matrix-assisted laser desorption ionization-time of flight mass spectrometry systems for identification of nonfermenting gram-negative bacilli isolated from cultures from cystic fibrosis patients. J Clin Microbiol 50(6):2034–2039. doi:10.1128/JCM.00330-12 CrossRefPubMedPubMedCentral Marko DC, Saffert RT, Cunningham SA, Hyman J, Walsh J, Arbefeville S, Howard W, Pruessner J, Safwat N, Cockerill FR, Bossler AD, Patel R, Richter SS (2012) Evaluation of the Bruker Biotyper and Vitek MS matrix-assisted laser desorption ionization-time of flight mass spectrometry systems for identification of nonfermenting gram-negative bacilli isolated from cultures from cystic fibrosis patients. J Clin Microbiol 50(6):2034–2039. doi:10.​1128/​JCM.​00330-12 CrossRefPubMedPubMedCentral
16.
go back to reference Martiny D, Busson L, Wybo I, El Haj RA, Dediste A, Vandenberg O (2012) Comparison of the Microflex LT and Vitek MS systems for routine identification of bacteria by matrix-assisted laser desorption ionization-time of flight mass spectrometry. J Clin Microbiol 50(4):1313–1325. doi:10.1128/JCM.05971-11 CrossRefPubMedPubMedCentral Martiny D, Busson L, Wybo I, El Haj RA, Dediste A, Vandenberg O (2012) Comparison of the Microflex LT and Vitek MS systems for routine identification of bacteria by matrix-assisted laser desorption ionization-time of flight mass spectrometry. J Clin Microbiol 50(4):1313–1325. doi:10.​1128/​JCM.​05971-11 CrossRefPubMedPubMedCentral
17.
go back to reference Pence MA, McElvania Tekippe E, Wallace MA, Burnham CA (2014) Comparison and optimization of two MALDI-TOF MS platforms for the identification of medically relevant yeast species. Eur J Clin Microbiol Infect Dis (in press) Pence MA, McElvania Tekippe E, Wallace MA, Burnham CA (2014) Comparison and optimization of two MALDI-TOF MS platforms for the identification of medically relevant yeast species. Eur J Clin Microbiol Infect Dis (in press)
18.
go back to reference Perez KK, Olsen RJ, Musick WL, Cernoch PL, Davis JR, Land GA, Peterson LE, Musser JM (2013) Integrating rapid pathogen identification and antimicrobial stewardship significantly decreases hospital costs. Arch Pathol Lab Med 137(9):1247–1254. doi:10.5858/arpa.2012-0651-OA CrossRefPubMed Perez KK, Olsen RJ, Musick WL, Cernoch PL, Davis JR, Land GA, Peterson LE, Musser JM (2013) Integrating rapid pathogen identification and antimicrobial stewardship significantly decreases hospital costs. Arch Pathol Lab Med 137(9):1247–1254. doi:10.​5858/​arpa.​2012-0651-OA CrossRefPubMed
19.
go back to reference Beekmann SE, Diekema DJ, Chapin KC, Doern GV (2003) Effects of rapid detection of bloodstream infections on length of hospitalization and hospital charges. J Clin Microbiol 41(7):3119–3125CrossRefPubMedPubMedCentral Beekmann SE, Diekema DJ, Chapin KC, Doern GV (2003) Effects of rapid detection of bloodstream infections on length of hospitalization and hospital charges. J Clin Microbiol 41(7):3119–3125CrossRefPubMedPubMedCentral
20.
go back to reference Barenfanger J, Drake C, Kacich G (1999) Clinical and financial benefits of rapid bacterial identification and antimicrobial susceptibility testing. J Clin Microbiol 37(5):1415–1418PubMedPubMedCentral Barenfanger J, Drake C, Kacich G (1999) Clinical and financial benefits of rapid bacterial identification and antimicrobial susceptibility testing. J Clin Microbiol 37(5):1415–1418PubMedPubMedCentral
22.
go back to reference Kang CI, Kim SH, Kim HB, Park SW, Choe YJ, Oh MD, Kim EC, Choe KW (2003) Pseudomonas aeruginosa bacteremia: risk factors for mortality and influence of delayed receipt of effective antimicrobial therapy on clinical outcome. Clin Infect Dis 37(6):745–751. doi:10.1086/377200 CrossRefPubMed Kang CI, Kim SH, Kim HB, Park SW, Choe YJ, Oh MD, Kim EC, Choe KW (2003) Pseudomonas aeruginosa bacteremia: risk factors for mortality and influence of delayed receipt of effective antimicrobial therapy on clinical outcome. Clin Infect Dis 37(6):745–751. doi:10.​1086/​377200 CrossRefPubMed
Metadata
Title
Evaluation of the Bruker Biotyper and VITEK MS MALDI-TOF MS systems for the identification of unusual and/or difficult-to-identify microorganisms isolated from clinical specimens
Authors
E. McElvania TeKippe
C.-A. D. Burnham
Publication date
01-12-2014
Publisher
Springer Berlin Heidelberg
Published in
European Journal of Clinical Microbiology & Infectious Diseases / Issue 12/2014
Print ISSN: 0934-9723
Electronic ISSN: 1435-4373
DOI
https://doi.org/10.1007/s10096-014-2183-y

Other articles of this Issue 12/2014

European Journal of Clinical Microbiology & Infectious Diseases 12/2014 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.